This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Balakumaran K, PhD
Group Leader - Analytical R&D, Small molecules and Peptides CDMO at Aurigene Pharmaceutical Services
Speaker

Profile

Balakumaran is a highly experienced professional in the CRDMO sector with a proven track record in research, development, and manufacturing of pharmaceutical ingredients, including peptides and small molecules. He expertly leads analytical method development, characterization, validation, technology transfer, and lifecycle management initiatives. Skilled in downstream process development for peptides, he specializes in chromatography purification and isolation techniques.

Possessing a strong blend of technical expertise and commercial insight, Balakumaran effectively integrates advanced analytical science with strategic business objectives. As a dynamic leader, he excels in guiding multidisciplinary teams to deliver projects successfully, while ensuring strict adherence to quality standards, regulatory compliance, and operational excellence.

His broad experience spans collaborating with R&D, manufacturing, and quality assurance to optimize processes, enhance productivity, and meet regulatory requirements. He brings a solutions-focused approach to troubleshooting complex analytical challenges, managing scale-up activities, and overseeing lifecycle management in fast-evolving and highly regulated environments.

Agenda Sessions

  • Attaching Novel Albumin Binders to Modulate Peptides Stability and Pharmacokinetics

    12:50